文献速递肿瘤 PET/CT放射性药物与辐射防护

肿瘤学中的全身PET-CT协议

Total Body PET-CT Protocols in Oncology.
PubMed 文献 · Semin Nucl Med · 2024-06-08

本文综述了长轴视野(LAFOV)PET-CT扫描仪(包括全身扫描仪)在肿瘤学中的专用PET采集协议,涵盖静态、动态及参数成像,并汇总了截至目前的文献数据。这些系统灵敏度最高可达标准轴视野(SAFOV)PET-CT的20倍,可改善病灶可检测性、缩短采集时间、降低示踪剂剂量,并首次实现全身动态PET扫描和参数成像。

要点

  • LAFOV PET-CT灵敏度最高可达SAFOV的20倍,改善病灶可检测性。
  • 可缩短静态全身PET采集时间、降低示踪剂剂量,并支持延迟扫描。
  • 首次实现全身动态PET和参数成像,有助于表征新放射性药物和评估治疗反应。

核心结论

  • LAFOV PET-CT扫描仪在肿瘤学中具有灵敏度高、采集时间短、示踪剂剂量低等优势,并支持全身动态和参数成像。
  • 进一步基于人工智能的技术发展可能在未来实现无CT衰减校正或超低剂量CT衰减校正,以及用于评估总代谢肿瘤体积的分割算法。

研究设计与样本

  • 本文为综述,旨在呈现LAFOV扫描仪用于肿瘤学研究的专用PET采集协议(包括静态、动态及参数扫描),并汇总截至目前的文献数据。

主要发现

  • LAFOV PET-CT灵敏度最高可达SAFOV PET-CT的20倍,因此病灶可检测性改善。
  • 静态全身测量的PET采集时间缩短、给予的放射性示踪剂剂量降低。
  • 能够以良好图像质量进行延迟扫描,这对长半衰期放射性核素和长生物分布时间药物(如89Zr标记抗体)的成像很重要。
  • 示踪剂剂量降低导致辐射暴露减少,可能有助于纵向研究,尤其是在肿瘤患者中评估治疗。
  • 静态全身研究采集时间缩短允许患者吞吐量显著提高;LAFOV PET-CT首次实现全身动态PET扫描和全身参数成像,灵敏度和时间分辨率提高使图像质量改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently developed long axial field of view (LAFOV) PET-CT scanners, including total body scanners, are already in use in a few centers worldwide. These systems have some major advantages over standard axial field of view (SAFOV) PET-CT scanners, mainly due to up to 20 times higher sensitivity and therefore improved lesion detectability. Other advantages are the reduction of the PET acquisition time for a static whole-body measurement, the reduction of the administered radiotracer dose, and the ability to perform delayed scans with good image quality, which is important for imaging radionuclides with long half-lives and pharmaceuticals with long biodistribution times, such as 89Zr-labeled antibodies. The reduction of the applied tracer dose leads to less radiation exposure and may facilitate longitudinal studies, especially in oncological patients, for the evaluation of therapy. The reduction in acquisition time for a static whole body (WB) study allows a markedly higher patient throughput. Furthermore, LAFOV PET-CT scanners enable for the first-time WB dynamic PET scanning and WB parametric imaging with an improved image quality due to increased sensitivity and time resolution. WB tracer kinetics is of particular interest for the characterization of novel radiopharmaceuticals and for a better biological characterization of cancer diseases, as well as for a more accurate assessment of the response to new targeted therapies. Further technological developments based on artificial intelligence (AI) approaches are underway and may in the future allow CT-less attenuation correction or ultralow dose CT for attenuation correction as well as segmentation algorithms for the evaluation of total metabolic tumor volume. The aim of this review is to present dedicated PET acquisition protocols for oncological studies with LAFOV scanners, including static and dynamic acquisition as well as parametric scans, and to present literature data to date on this topic.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C, et al. Total Body PET-CT Protocols in Oncology. Semin Nucl Med. 2024. PMID: 38851935. doi:10.1053/j.semnuclmed.2024.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。